Healthy male and/or female subjects between the ages of 18 and 55 years, inclusive; Body
Mass Index (BMI) of 18 to 30 kg/m2; and a total body weight >50 kg (110 lbs). A BMI lower
limit of 17.5 kg/m2 may be rounded up to 18.0 kg/m2; a BMI upper limit of 30.5 kg/m2 may be
rounded down to 30.0 kg/m2 and will be acceptable for inclusion.
Evidence or history of clinically significant hematological, renal, endocrine, pulmonary,
gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease;
Treatment with an investigational drug within 30 days or 5 half-lives (whichever is longer)
preceding the first dose of study medication; Use of tobacco- or nicotine-containing
products in excess of the equivalent of 5 cigarettes per day.